These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 21813587)
1. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587 [TBL] [Abstract][Full Text] [Related]
2. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384 [TBL] [Abstract][Full Text] [Related]
6. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989 [TBL] [Abstract][Full Text] [Related]
7. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094 [TBL] [Abstract][Full Text] [Related]
8. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Mok CC; Ho LY; Leung HW; Wong LG Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493 [TBL] [Abstract][Full Text] [Related]
9. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis. Yang XW; Tan Y; Yu F; Zhao MH Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716 [TBL] [Abstract][Full Text] [Related]
10. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
11. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations. Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108 [TBL] [Abstract][Full Text] [Related]
12. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534 [TBL] [Abstract][Full Text] [Related]
13. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738 [TBL] [Abstract][Full Text] [Related]
14. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Julkunen H; Ekblom-Kullberg S; Miettinen A Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294 [TBL] [Abstract][Full Text] [Related]
15. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. Kiani AN; Johnson K; Chen C; Diehl E; Hu H; Vasudevan G; Singh S; Magder LS; Knechtle SJ; Petri M J Rheumatol; 2009 Oct; 36(10):2224-30. PubMed ID: 19648301 [TBL] [Abstract][Full Text] [Related]
16. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis. Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471 [TBL] [Abstract][Full Text] [Related]
18. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis. Tan Y; Zhou W; Yu F; Fang Q; Yang HZ; Zhao MH Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805 [TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity. Emad G; Al-Barshomy SM Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906 [TBL] [Abstract][Full Text] [Related]
20. Anti-C1q autoantibodies in lupus nephritis. Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]